Latest News & Features
Big Pharma
A district court of appeal has paused MSN Pharmaceuticals’ launch | Result comes days after the Federal Circuit restored Novartis’ patent and overturned a decision in favour of MSN | Request is one in a flurry of filings between the pair over the heart-failure drug. 16 January 2025
Careers
Partner plus team of four patent attorneys and four paralegals join Munich office | Firm says the addition strengthens its position in German and international markets. 16 January 2025
Europe
New analysis examines funding gap for European startups and where to find investment | UK’s active VC market bucks trend in Europe where tech funding largely driven by public programmes. 16 January 2025
Careers
Ex-Corrs Chambers Westgarth pharma specialist joins firm’s growing litigation practice. 16 January 2025
Americas
Join us as we delve into the complexities of international harmonisation and global patent strategies in the ever-evolving landscape of IP rights. 14 January 2025
Careers
IP specialist joins firm’s Bristol office | Transaction expert has advised AstraZeneca, Cancer Research Horizons, and other high-profile clients. 14 January 2025
Big Pharma
Federal circuit reverses district court’s ruling to revive combination patent | Novartis says patent has paediatric exclusivity expiring in July 2025. 14 January 2025
Europe
Company faces setback as EPO revokes patent for a C1-esterase inhibitor treatment | Patent aims at preventing antibody-mediated rejection in kidney transplant patients | Court cites insufficient clinical trial data. 9 January 2025
Careers
Skilled in microbiome, medical devices and next generation diagnostics, the new partner is skilled in creating IP strategies for startups, spinouts and SMEs. 9 January 2025
Americas
PTAB determines all but one of challenged claims unpatentable | Decision is latest instalment in clash over electrocardiogram technology | Apple bid to stop ‘AliveCor’s rampant infringement’ backfires. 9 January 2025